Alginate Nanoparticles Containing Curcumin and Resveratrol: Preparation, Characterization, and In Vitro Evaluation Against DU145 Prostate Cancer Cell Line

AAPS PharmSciTech

Volumn 18, Issue 7, 2017, Pages 2814-2823

  Saralkar, Pushkar ^a   Dash, Alekha K ^b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b CREIGHTON UNIVERSITY   (United States)

Author keywords

calcium alginate; curcumin; DU145; nanoparticles; resveratrol

Indexed keywords

CALCIUM ALGINATE; CURCUMIN; NANOPARTICLE; RESVERATROL; ALGINIC ACID; ANTINEOPLASTIC AGENT; GLUCURONIC ACID; HEXURONIC ACID; STILBENE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CROSS LINKING; CYTOTOXICITY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; DRUG SCREENING; DRUG SOLUBILITY; DRUG SOLUTION; DRUG SYNTHESIS; DU145 CELL LINE; EMULSION; HUMAN; IN VITRO STUDY; MOISTURE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE CHARGE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ZETA POTENTIAL; CHEMISTRY; DRUG RELEASE; MALE; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ALGINATES; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CURCUMIN; DRUG LIBERATION; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; MALE; NANOPARTICLES; PARTICLE SIZE; PROSTATIC NEOPLASMS; STILBENES;

EID: 85017278025     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-017-0772-7     Document Type: Article

References (54)

1. American Cancer Society Facts and Figures 2016.
2. Devlin H-L, Mudryj M. Progression of prostate cancer: multiple pathways to androgen independence. Cancer Lett [Internet]. Elsevier; 2009 18 [cited 2016 Jun 5];274(2):177–86. Available from: http://www.cancerletters.info/article/S0304383508004588/fulltext.
3. Oudard S. Progress in emerging therapies for advanced prostate cancer. Cancer Treat Rev [Internet]. 2013 [cited 2016 Jun 5];39(3):275–89. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23107383.
4. Chattopadhyay Ishita, Biswas, Kaushik Uday Bandyopadhyay and RK Banerjee. Turmeric and Curcumin: Biological actions and medical applications. Curr Sci. Volume 87.
5. Fujisawa S, Atsumi T, Ishihara M, Kadoma Y. Cytotoxicity, ROS-generation activity and radical-scavenging activity of curcumin and related compounds. Anticancer Res. 2004;24:563–70.
6. Tønnesen HH, Másson M, Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm [Internet]. 2002 [cited 2016 Mar 29];244(1–2):127–35. Available from: http://www.sciencedirect.com/science/article/pii/S037851730200323X.
7. Hsu C-H, Cheng A-L. Clinical studies with curcumin. Adv Exp Med Biol [Internet]. 2007 [cited 2016 May 20];595:471–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17569225.
8. Chandran B, Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res [Internet]. 2012 [cited 2016 Apr 27];26(11):1719–25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22407780.
9. Duvoix A, Blasius R, Delhalle S, Schnekenburger M, Morceau F, Henry E, et al. Chemopreventive and therapeutic effects of curcumin. Cancer Lett [Internet]. 2005 [cited 2016 May 21];223(2):181–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15896452.
10. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci [Internet]. 2006 [cited 2016 Mar 27];78(18):2081–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16413584.
11. Hahm E-R, Gho YS, Park S, Park C, Kim K-W, Yang C-H. Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis. Biochem Biophys Res Commun [Internet]. 2004 [cited 2016 May 21];321(2):337–44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15358181.
12. Chen H, Zhang ZS, Zhang YL, Zhou DY. Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. Anticancer Res [Internet]. 1999 [cited 2016 May 21];19(5A):3675–80. Available from: http://europepmc.org/abstract/med/10625938.
13. Shi M, Cai Q, Yao L, Mao Y, Ming Y, Ouyang G. Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells. Cell Biol Int [Internet]. 2006 [cited 2016 May 21];30(3):221–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16376585.
14. Dorai T, Gehani N, Katz A. Therapeutic potential of curcumin in human prostate cancer-I. curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells. Prostate Cancer Prostatic Dis [Internet]. Nature Publishing Group; 2000 [cited 2016 May 21];3(2):84–93. Available from: http://www.nature.com/pcan/journal/v3/n2/abs/4500399a.html.
15. Bharti AC, Donato N, Singh S, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood [Internet]. American Society of Hematology; 2003 [cited 2016 May 21];101(3):1053–62. Available from: http://www.bloodjournal.org/content/101/3/1053.abstract
16. Kundu JK, Surh Y-J. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett [Internet]. 2008 [cited 2016 May 21];269(2):243–61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18550275.
17. resveratrol | C14H12O3 - PubChem [Internet]. [cited 2016 May 22]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/445154#section=Vapor-Pressure.
18. Neves AR, Lucio M, Lima JLC, Reis S. Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions. Curr Med Chem [Internet]. 2012 [cited 2016 May 22];19(11):1663–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22257059.
19. Almeida L, Vaz-da-Silva M, Falcão A, Soares E, Costa R, Loureiro AI, et al. Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Mol Nutr Food Res [Internet]. 2009 [cited 2016 May 22];53 Suppl 1:S7–15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19194969.
20. Athar M, Back JH, Kopelovich L, Bickers DR, Kim AL. Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. Arch Biochem Biophys [Internet]. 2009 [cited 2016 May 22];486(2):95–102. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2749321&tool=pmcentrez&rendertype=abstract.
21. Clément M V, Hirpara JL, Chawdhury SH, Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood [Internet]. 1998 [cited 2016 May 22];92(3):996–1002. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9680369.
22. Cao Y, Fu Z-D, Wang F, Liu H-Y, Han R. Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants. J Asian Nat Prod Res [Internet]. 2005 [cited 2016 Apr 18];7(3):205–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15621628.
23. Awad AB, Burr AT, Fink CS. Effect of resveratrol and beta-sitosterol in combination on reactive oxygen species and prostaglandin release by PC-3 cells. Prostaglandins Leukot Essent Fatty Acids [Internet]. 2005 [cited 2016 May 22];72(3):219–26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15664307.
24. Aziz MH, Nihal M, Fu VX, Jarrard DF, Ahmad N. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3′-kinase/Akt pathway and Bcl-2 family proteins. Mol Cancer Ther [Internet]. 2006 May 1 [cited 2016 May 22];5(5):1335–41. Available from: http://mct.aacrjournals.org/content/5/5/1335.short.
25. Pozo-Guisado E, Merino JM, Mulero-Navarro S, Lorenzo-Benayas MJ, Centeno F, Alvarez-Barrientos A, et al. Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-?B. Int J Cancer [Internet]. 2005 [cited 2016 Apr 5];115(1):74–84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15688415.
26. Golkar L, Ding X-Z, Ujiki MB, Salabat MR, Kelly DL, Scholtens D, et al. Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1. J Surg Res [Internet]. 2007 Apr [cited 2016 May 22];138(2):163–9. Available from: https://nebraska.pure.elsevier.com/en/publications/resveratrol-inhibits-pancreatic-cancer-cell-proliferation-through.
27. ROLE OF RESVERATROL IN PREVENTION AND THERAPY OF CANCER: PRECLINICAL AND CLINICAL STUDIES [Internet]. [cited 2016 Jun 5]. Available from: http://www.chiro.org/nutrition/ABSTRACTS/Role_of_Resveratrol.shtml.
28. Kelkel M, Jacob C, Dicato M, Diederich M. Potential of the dietary antioxidants resveratrol and curcumin in prevention and treatment of hematologic malignancies. Molecules [Internet]. Molecular Diversity Preservation International; 2010 [cited 2016 May 23];15(10):7035–74. Available from: http://www.mdpi.com/1420-3049/15/10/7035.
29. Liu Y, Wu Y-M, Yu Y, Cao C-S, Zhang J-H, Li K, et al. Curcumin and resveratrol in combination modulate drug-metabolizing enzymes as well as antioxidant indices during lung carcinogenesis in mice. Hum Exp Toxicol [Internet]. 2015 [cited 2016 May 24];34(6):620–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25632966.
30. Masuelli L, Di Stefano E, Fantini M, Mattera R, Benvenuto M, Marzocchella L, et al. Resveratrol potentiates the in vitro and in vivo anti-tumoral effects of curcumin in head and neck carcinomas. Oncotarget [Internet]. 2014 [cited 2016 May 24];5(21):10745–62. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4279407&tool=pmcentrez&rendertype=abstract.
31. Narayanan NK, Nargi D, Randolph C, Narayanan BA. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int J cancer [Internet]. 2009 [cited 2016 May 24];125(1):1–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19326431.
32. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev [Internet]. 2003 [cited 2014 Jul 14];55(3):329–47. Available from: http://www.sciencedirect.com/science/article/pii/S0169409X02002284.
33. Torchilin VP. Drug targeting. Eur J Pharm Sci [Internet]. 2000 Oct [cited 2016 May 24];11:S81–91. Available from: http://www.sciencedirect.com/science/article/pii/S0928098700001664.
34. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res [Internet]. 1986 [cited 2016 Mar 10];46(12 Pt 1):6387–92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2946403.
35. Goh CH, Heng PWS, Chan LW. Alginates as a useful natural polymer for microencapsulation and therapeutic applications [Internet]. 2012 [cited 2016 May 26]. Available from: https://scholarbank.nus.edu.sg/handle/10635/106609.
36. Lee KY, Mooney DJ. Alginate: properties and biomedical applications. Prog Polym Sci [Internet]. 2012 Jan [cited 2014 Jul 10];37(1):106–26. Available from: http://www.sciencedirect.com/science/article/pii/S0079670011000918.
37. Grant GT, Morris ER, Rees DA, Smith PJC, Thom D. Biological interactions between polysaccharides and divalent cations: The egg-box model. FEBS Lett [Internet]. 1973 [cited 2016 Apr 21];32(1):195–8. Available from: http://doi.wiley.com/10.1016/0014-5793%252873%252980770-7.
38. Astete CE, Sabliov CM, Watanabe F, Biris A. Ca(2+) cross-linked alginic acid nanoparticles for solubilization of lipophilic natural colorants. J Agric Food Chem [Internet]. 2009 [cited 2016 Jun 24];57(16):7505–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19645512.
39. Douglas KL, Tabrizian M. Effect of experimental parameters on the formation of alginate-chitosan nanoparticles and evaluation of their potential application as DNA carrier. J Biomater Sci Polym Ed [Internet]. 2005 [cited 2016 Jun 25];16(1):43–56. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15796304.
40. De S, Robinson D. Polymer relationships during preparation of chitosan–alginate and poly-l-lysine–alginate nanospheres. J Control Release. 2003;89(1):101–12.
41. Date P V, Samad A, Devarajan P V. Freeze thaw: a simple approach for prediction of optimal cryoprotectant for freeze drying. AAPS PharmSciTech [Internet]. Springer; 2010 [cited 2016 Jun 25];11(1):304–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20182826.
42. Acharya S, Sahoo SK. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev. 2011;63(3):170–83.
43. Gratton SEA, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME, et al. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci [Internet]. National Academy of Sciences; 2008 19 [cited 2016 Jun 25];105(33):11613–8. Available from: http://www.pnas.org/cgi/doi/10.1073/pnas.0801763105.
44. Mohanty C, Sahoo SK. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials. 2010;31(25):6597–611.
45. Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MNVR. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci. 2009;37(3):223–30.
46. Trela BC, Waterhouse AL. Resveratrol: Isomeric Molar Absorptivities and Stability. J Agric Food Chem [Internet]. American Chemical Society; 1996 [cited 2016 May 22];44(5):1253–1257. doi:10.1021/jf9504576.
47. Sun J, Bi C, Chan HM, Sun S, Zhang Q, Zheng Y. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability. Colloids Surfaces B Biointerfaces. 2013;111:367–75.
48. Yu H, Huang Q. Investigation of the Absorption Mechanism of Solubilized Curcumin Using Caco-2 Cell Monolayers. Am Chem Soc; 2011.
49. Singh R, Tønnesen HH, Kristensen S, Berg K, Dahl TA, Bilski P, et al. The influence of Pluronics® on dark cytotoxicity, photocytotoxicity, localization and uptake of curcumin in cancer cells: studies of curcumin and curcuminoids XLIX. Photochem Photobiol Sci [Internet]. The Royal Society of Chemistry; 2013 [cited 2016 Jul 19];12(3):559–75. Available from: http://xlink.rsc.org/?DOI=C2PP25249J.
50. Henry C, Vitrac X, Decendit A, Ennamany R, Krisa S, Mérillon J-M. Cellular uptake and efflux of trans-Piceid and its Aglycone trans-resveratrol on the apical membrane of human intestinal Caco-2 cells. J Agric Food Chem. 2005;53(3):798–803.
51. Lançon A, Delma D, Osman H, Thénot J-P, Latruffe BJN. Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process. Biochem Biophys Res Commun. 2004;316(4):1132–7.
52. Yallapu MM, Jaggi M, Chauhan SC. β-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surfaces B Biointerfaces. 2010;79(1):113–25.
53. Yallapu MM, Othman SF, Curtis ET, Gupta BK, Jaggi M, Chauhan SC. Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy. Biomaterials. 2011;32(7):1890–905.
54. Das RK, Kasoju N, Bora U. Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine [Internet]. 2010 [cited 2016 May 27];6(1):153–60. Available from: http://www.sciencedirect.com/science/article/pii/S1549963409001099.